The combination of serum CA-125, CA153, and CEA has a certain value in the diagnosis of triple-negative breast cancer, and high levels of CA-125 and CA153 after the operation in triple-negative breast cancerPatients indicate poor prognosis. The gene discussed is CEACAM5; the disease is triple-negative breast carcinoma.